The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Cerebrovascular Disease, the Apolipoprotein e4 Allele, and Cognitive Decline in a Community-Based Study of Elderly Men
Open accessAbstract
Background and Purpose Cerebrovascular disease and the apolipoprotein e4 ( APOE * 4 ) allele are both important risk factors for cognitive decline. We investigated the combined effect of APOE * 4 and cerebrovascular disease on cognitive decline. Methods Data are from a cohort of 353 men, aged 69 to 89 years at baseline, living in Zutphen, Netherlands. The 30-point Mini-Mental State Examination (MMSE) was used to measure cognitive decline (drop of >2 points) from 1990 to 1993 (14% of the sample). Odds ratios (OR [95% confidence interval]) for cognitive decline were adjusted for age, education, and baseline MMSE score. Results Compared with those without APOE * 4 and without a history of cerebrovascular disease, the adjusted OR was 4.7 (1.7 to 12.7) for subjects without APOE * 4 but with cerebrovascular disease, 3.3 (1.6 to 6.8) for those with APOE * 4 and no cerebrovascular disease, and 17.2 (2.7 to 110.0) for those with both risk factors. The risk for cerebrovascular disease and APOE * 4 combined was more than expected from the separate effects. The combined risk of coronary heart disease and APOE * 4 was 6.1 (1.7 to 22.3). The analysis of cardiovascular risk factors showed that the risk of cognitive decline was highest in subjects with both APOE * 4 and a high cholesterol level, high fibrinogen level, normal blood pressure, or diabetes mellitus. Conclusions Cerebrovascular disease and APOE * 4 may have a synergistic effect on cognitive decline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Mini‐Mental State Examination: A Comprehensive Review
Tombaugh, T. N., & McIntyre, N. J. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb01992.x · Cited by 5,152
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Apolipoprotein E polymorphism and Alzheimer's disease
Poirier, J., Bertrand, P., Poirier, J., Kogan, S., Gauthier, S., Poirier, J., Gauthier, S., Davignon, J., Bouthillier, D., & Davignon, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91705-q · Cited by 1,108
Cited by
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459
Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies
Cukierman, T., Gerstein, H. C., & Williamson, J. D. (2005) · Diabetologia · doi:10.1007/s00125-005-0023-4 · Cited by 1,049
Type 2 diabetes mellitus, cognitive impairment and dementia
Stewart, R., & Liolitsa, D. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00027.x · Cited by 562
Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer
Gazzerro, P., Proto, M. C., Gangemi, G., Malfitano, A. M., Ciaglia, E., Pisanti, S., Santoro, A., Laezza, C., & Bifulco, M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004994 · Cited by 457
Serum Lipoprotein Levels, Statin Use, and Cognitive Function in Older Women
Yaffe, K., Barrett-Connor, E., Lin, F., & Grady, D. (2002) · Archives of Neurology · doi:10.1001/archneur.59.3.378 · Cited by 439
Anstey, K. J., Lipnicki, D. M., & Low, L.-F. (2008) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000310778.20870.ae · Cited by 437
Anstey, K. J., Ashby-Mitchell, K., & Peters, R. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160826 · Cited by 360
“One study reported on the association of HDL-C and cognitive decline and found no association [50] and two reported data with long-term follow-ups and are described below [51, 53].”
BackgroundHassan, A. (2000) · Brain · doi:10.1093/brain/123.9.1784 · Cited by 392
Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins
Carmelli, D., DeCarli, C., Swan, G. E., Jack, L. M., Reed, T., Wolf, P. A., & Miller, B. L. (1998) · Stroke · doi:10.1161/01.str.29.6.1177 · Cited by 321
Allen, K. V., Frier, B. M., & Strachan, M. W. J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.054 · Cited by 319
Relationship Between ApoE, MRI Findings, and Cognitive Function in the Cardiovascular Health Study
Kuller, L. H., Shemanski, L., Manolio, T., Haan, M., Fried, L., Bryan, N., Burke, G. L., Tracy, R., & Bhadelia, R. (1998) · Stroke · doi:10.1161/01.str.29.2.388 · Cited by 310
Irie, F., Fitzpatrick, A. L., Lopez, O. L., Kuller, L. H., Peila, R., Newman, A. B., & Launer, L. J. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.29 · Cited by 305
Self-citationDiabetes mellitus and dementia
Pasquier, F., Boulogne, A., Leys, D., & Fontaine, P. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70298-7 · Cited by 276
Deckers, K., Schievink, S. H. J., Rodriquez, M. M. F., van Oostenbrugge, R. J., van Boxtel, M. P. J., Verhey, F. R. J., & Köhler, S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0184244 · Cited by 271
Kanaya, A. M., Barrett-Connor, E., Gildengorin, G., & Yaffe, K. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.12.1327 · Cited by 255
Beydoun, M. A., Kaufman, J. S., Satia, J. A., Rosamond, W., & Folsom, A. R. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.4.1103 · Cited by 253
Severe carotid stenosis and impaired cerebral hemodynamics can influence cognitive deterioration
Balestrini, S., Perozzi, C., Altamura, C., Vernieri, F., Luzzi, S., Bartolini, M., Provinciali, L., & Silvestrini, M. (2013) · Neurology · doi:10.1212/wnl.0b013e318295d71a · Cited by 126
APOE ε4 does not predict mortality, cognitive decline, or dementia in the oldest old
Juva, K., Verkkoniemi, A., Viramo, P., Polvikoski, T., Kainulainen, K., Kontula, K., & Sulkava, R. (2000) · Neurology · doi:10.1212/wnl.54.2.412 · Cited by 108
Ankle-to-Brachial Index and Dementia: The Honolulu-Asia Aging Study
Laurin, D., Masaki, K. H., White, L. R., & Launer, L. J. (2007) · Circulation · doi:10.1161/circulationaha.106.686477 · Cited by 90
Self-citationType 2 diabetes and cognitive impairment
Strachan, M. W. J., Frier, B. M., & Deary, I. J. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00855.x · Cited by 59
Age, vascular risk, and cognitive decline in an older, British, African-Caribbean population.
Stewart, R., Prince, M., & Mann, A. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51504.x · Cited by 45
Is the distinction between Alzheimer's disease and vascular dementia possible and relevant?
Ravona-Springer, R., Davidson, M., & Noy, S. (2003) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2003.5.1/rravonaspringer · Cited by 18
Korthauer, L. E., Giugliano, R. P., Guo, J., Sabatine, M. S., Sever, P., Keech, A., Atar, D., Kurtz, C., Ruff, C. T., Mach, F., et al. (2022) · PLOS ONE · doi:10.1371/journal.pone.0266615 · Cited by 11
Metadata
- Authors
- Kalmijn, S., Feskens, E. J. M., Launer, L. J., & Kromhout, D.
- Venue
- Stroke
- Published
- 1996-12
- Volume
- 27
- Issue
- 12
- Pages
- 2230-2235
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2122149954
- Cited by
- 160
- References
- 3
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.